Qiuhong Yang Selected Research

aerolysin

3/2022	Sanguinarine Protects Channel Catfish against Aeromonas hydrophila Infection by Inhibiting Aerolysin and Biofilm Formation.
12/2021	Luteolin decreases the pathogenicity of Aeromonas hydrophila via inhibiting the activity of aerolysin.
4/2020	Thymol Protects Channel Catfish from Aeromonas hydrophila Infection by Inhibiting Aerolysin Expression and Biofilm Formation.
1/2018	Morin Protects Channel Catfish From Aeromonas hydrophila Infection by Blocking Aerolysin Activity.
11/2017	Magnolol protects channel catfish from Aeromonas hydrophila infection via inhibiting the expression of aerolysin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiuhong Yang Research Topics

Disease

12	Neoplasms (Cancer) 09/2021 - 11/2011
4	Infections 03/2022 - 11/2017
3	Sepsis (Septicemia) 05/2021 - 10/2019
2	Inflammation (Inflammations) 07/2015 - 12/2010
2	Squamous Cell Carcinoma of Head and Neck 01/2015 - 04/2012
2	Head and Neck Neoplasms (Head and Neck Cancer) 08/2014 - 04/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022
1	Cicatrix (Scar) 02/2022
1	Hemolysis 12/2021
1	Embryo Loss 09/2021
1	Fetal Resorption 09/2021
1	Necrosis 09/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Communicable Diseases (Infectious Diseases) 04/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 05/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Neoplasm Metastasis (Metastasis) 08/2014
1	Melanoma (Melanoma, Malignant) 03/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2011
1	Stroke (Strokes) 01/2011

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 09/2016 - 11/2011
5	aerolysinIBA 03/2022 - 11/2017
5	Hyaluronic Acid (Hyaluronan)IBA 09/2016 - 03/2014
3	Pharmaceutical PreparationsIBA 01/2015 - 08/2014
2	Caspase 3 (Caspase-3)IBA 01/2020 - 11/2011
1	sanguinarineIBA 03/2022
1	InterleukinsIBA 09/2021
1	Cytochromes c (Cytochrome c)IBA 09/2021
1	Interleukin-12 (IL 12)IBA 09/2021
1	Interleukin-10 (Interleukin 10)IBA 09/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2021
1	InterferonsIBA 09/2021
1	tiamulinIBA 01/2021
1	1-O-hexyl-2,3,5-trimethylhydroquinoneIBA 01/2021
1	ThymolIBA 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2020
1	tetramethylpyrazineIBA 01/2020
1	NMDA receptor A1IBA 01/2020
1	Long Noncoding RNAIBA 10/2019
1	LipopolysaccharidesIBA 10/2019
1	human MIRN346 microRNAIBA 10/2019
1	morinIBA 01/2018
1	magnololIBA 11/2017
1	PlatinumIBA 09/2016
1	NanoconjugatesIBA 09/2016
1	Drug CarriersIBA 01/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Proteins (Proteins, Gene)FDA Link 07/2015
1	HMGB1 Protein (HMG1)IBA 07/2015
1	Nucleotide AptamersIBA 05/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2015
1	AntigensIBA 05/2015
1	Bromodeoxyuridine (BrdU)IBA 05/2015
1	SolventsIBA 05/2015
1	ParaffinIBA 05/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 05/2015
1	AndrogensIBA 05/2015
1	MicellesIBA 01/2015
1	SolutionsIBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	cabozantinibIBA 01/2015
1	LanthanumIBA 01/2015
1	LigandsIBA 08/2014
1	PolymersIBA 04/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2012
1	SugarsIBA 04/2012
1	Caspase 9IBA 11/2011
1	Coloring Agents (Dyes)IBA 11/2011
1	Contrast MediaIBA 11/2011
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2011
1	VaccinesIBA 12/2010
1	DNA VaccinesIBA 12/2010
1	EpitopesIBA 12/2010
1	A-Form DNA (A-DNA)IBA 12/2010
1	Immunoglobulin E (IgE)IBA 12/2010
1	Toll-Like Receptor 9IBA 12/2010
1	Immunoglobulin G (IgG)IBA 12/2010
1	AllergensIBA 12/2010

Therapy/Procedure

3	Therapeutics 01/2015 - 04/2012
3	Drug Therapy (Chemotherapy) 03/2014 - 11/2011
1	Radiofrequency Ablation 05/2022
1	Cesarean Section (Caesarean Section) 02/2022
1	Catheters 05/2021
1	Oral Administration 01/2021
1	Ligation 01/2020
1	Punctures 01/2020
1	Injections 09/2016
1	Castration 05/2015
1	Subcutaneous Injections 01/2015
1	Precision Medicine 01/2015
1	Intravenous Administration 01/2015
1	Induced Hyperthermia (Thermotherapy) 01/2015